The Global Forum for Health Research is part of COHRED, a non-governmental organization committed to research and innovation for health.
The Global Forum is headquartered in Geneva, Switzerland, close to international organizations such as the World Health Organization, the International Labour Organization, the International Federation of Red Cross and Red Crescent Societies, the United Nations Research Institute for Social Development and the World Intellectual Property Organization.
Global Health Council (GHC) is the leading membership organization supporting and connecting advocates, implementers and stakeholders around global health priorities worldwide
To improve health globally through increased investment, robust policies and the power of the collective voice.
At the Howard Hughes Medical Institute, we believe in the power of individuals to advance science through research and science education, making discoveries that benefit humanity.
CDC works 24/7 to protect America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.
The International Development Research Centre (IDRC) is a Canadian Crown corporation established by an act of Parliament in 1970 to help developing countries find solutions to their problems.
We encourage and support researchers and innovators in those countries to find practical, long-term solutions to the social, economic, and environmental problems their societies face. Our goal is to find ways to reduce poverty, improve health, support innovation, and safeguard the environment.
communities and citizens to do the same.
The International Federation of Red Cross and Red Crescent Societies (IFRC) is the world's largest humanitarian organization, providing assistance without discrimination as to nationality, race, religious beliefs, class or political opinions.
Main research themes:
Development of a malaria vaccine based on genetically attenuated parasites (read more ....)
•Identification and analysis of parasite proteins that are (putative) targets for subunit vaccines
•Identification and analysis of parasite proteins that are (putative) targets for drugs
•Analysis of parasite-host interactions involved in pathology and disease
Liverpool School of Tropical Medicine (LSTM) was the first institution in the world dedicated to research and teaching in the field of tropical medicine and as we approach our 115th anniversary, we continue to be a leading international institution in the fight against infectious, debilitating and disabling diseases. As a registered charity, we work in over 60 countries worldwide, often in very difficult circumstances, to fulfil our mission of reducing the burden of sickness and mortality in disease endemic countries through the delivery of effective interventions which improve human health and are relevant to the poorest communities.
The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice. - See more at: http://www.lshtm.ac.uk/aboutus/introducing/index.html#sthash.10tS1DwY.dpuf
The Malaria Centre was established in 1998 to facilitate interdisciplinary research at the School as well as support and promote links with research in malaria endemic countries. Who we are The Centre brings together around 200 scientists, postgraduate students and support staff from all 3 faculties in LSHTM (the Faculty of Infectious and Tropical Diseases; the Faculty of Epidemiology and Population Health; and the Faculty of Public Health and
The Malaria Reference Laboratory provides an integrated service for public health in relation to malaria. It combines reference and diagnostic parasitology of malaria with surveillance of all imported malaria reported in the United Kingdom (UK), analysing the results and using these, together with wide consultation to develop national policy on prevention of imported malaria, which it then disseminates widely. The advisory activities interpret policy for particular individual needs, especially through the health service. Policy is moved into implementation by the laboratory staff writing for various medical, pharmaceutical and lay audiences, briefing the media, contributing to continuing medical education for doctors and practice nurses, and responding to telephone queries from them and from the public.
This site is in existence for the following reasons:
Display my collection online as an exhibit.
Sell my duplicates that I buy in collections
Trade with other malaria stamp collectors.
Restart the Malaria Philatelists International (MPI)
Supporting the long-term goal of eradicating malaria
MVI's research and development (R&D) strategy supports the long-term goal of eradicating malaria. The strategy aims to build on the success of GlaxoSmithKline Biologicals' RTS,S vaccine candidate that is now in the final stage of development in seven African countries. The strategy also includes approaches that seek to block malaria transmission and approaches that use weakened, whole parasites to protect against the disease.
In November 1996, Glaxo Wellcome announced the initiation of a controlled donation program for Malarone, a highly effective new anti-malarial, in partnership with The Task Force for Child Survival and Development. The purpose of the Malarone Donation Program (MDP) is to help combat the problem of drug resistant malaria in endemic countries where cost often limits access to new medicines.
MMV, a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999.
Our mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs.
Our vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.
MEDINET is a non-profit initiative of Medical Information Group (MIG) to create an Online Community of Medical, Pharmaceutical & Health NGO Professionals in Bangladesh. Access to MEDINET is without charge.
MEDINET also hosts an international Internet based free forum named <mignet> to discuss issues of health and medical education in Bangladesh and also other health matters of interest.
Clinical Resources Information to support patient care activities and clinical process improvement
Mekong malaria forum: information exchange on malaria control in Southeast Asia
International Studies and Programs (ISP) provides leadership to facilitate cross-college and cross-continent research and project collaborations. We believe when you reach across disciplines, institutions and boundaries you can harness talent and bright ideas from around the world–in a network of networks–to address the world's most pressing problems and most promising opportunities.
Our international units and institutes work on behalf of the entire university to mobilize Michigan State University's (MSU) research capacity, enhance educational programs, strengthen international experiences, support foreign language instruction and build international partnerships.
These efforts help expand and deepen MSU's global research and create a robust resource of in-the-world knowledge, which is essential for advancing well-being and assuring the marginalized and disadvantage benefit from our efforts.
Morbidity and Mortality Weekly Report (MMWR)